JP2013543872A5 - - Google Patents

Download PDF

Info

Publication number
JP2013543872A5
JP2013543872A5 JP2013540105A JP2013540105A JP2013543872A5 JP 2013543872 A5 JP2013543872 A5 JP 2013543872A5 JP 2013540105 A JP2013540105 A JP 2013540105A JP 2013540105 A JP2013540105 A JP 2013540105A JP 2013543872 A5 JP2013543872 A5 JP 2013543872A5
Authority
JP
Japan
Prior art keywords
composition
interferon
concentration
stable
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013540105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013543872A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/061759 external-priority patent/WO2012071366A1/en
Publication of JP2013543872A publication Critical patent/JP2013543872A/ja
Publication of JP2013543872A5 publication Critical patent/JP2013543872A5/ja
Pending legal-status Critical Current

Links

JP2013540105A 2010-11-22 2011-11-22 インターフェロン−βの安定に保存される組成物 Pending JP2013543872A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41629110P 2010-11-22 2010-11-22
US61/416,291 2010-11-22
PCT/US2011/061759 WO2012071366A1 (en) 2010-11-22 2011-11-22 Stable preserved compositions if interferon-beta

Publications (2)

Publication Number Publication Date
JP2013543872A JP2013543872A (ja) 2013-12-09
JP2013543872A5 true JP2013543872A5 (https=) 2014-01-30

Family

ID=46146183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013540105A Pending JP2013543872A (ja) 2010-11-22 2011-11-22 インターフェロン−βの安定に保存される組成物

Country Status (7)

Country Link
US (1) US20120269770A1 (https=)
EP (1) EP2643469A1 (https=)
JP (1) JP2013543872A (https=)
AU (1) AU2011331992A1 (https=)
CA (1) CA2818671A1 (https=)
MX (1) MX2013005699A (https=)
WO (1) WO2012071366A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014130811A1 (en) * 2013-02-22 2014-08-28 Biogen Idec Ma Inc Interferon beta formulation
WO2016163764A2 (ko) * 2015-04-07 2016-10-13 에이비온 주식회사 인터페론 베타 변이체의 안정화 제제
FI126979B (en) * 2016-02-29 2017-09-15 Faron Pharmaceuticals Oy Lyophilized pharmaceutical formulation and its use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1272252B (it) * 1994-05-16 1997-06-16 Applied Research Systems Formulazioni liquide di interferone beta
US6887462B2 (en) * 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
UA92146C2 (ru) * 2004-06-01 2010-10-11 Эйрэс Трейдинг С.А. Стабилизированная жидкая композиция, которая содержит интерферон
BRPI0821029A2 (pt) * 2007-12-20 2015-06-16 Merck Serono Sa Fomulações de peg-interferon-beta

Similar Documents

Publication Publication Date Title
ME02312B (me) DERIVATI PIRAZOLOSPIROKETONA, NAMIJENJENI UPOTREBI KAO INHIBITORI ACETIL-CoA-KARBOKSILAZE
HRP20171512T1 (hr) Derivati betulina
ME02182B (me) TERAPEUTSKA KOMBINACIJA KOJA SADRŽI DOLUTEGRAVIR, ABAKAVIR l LAMIVUDIN
HRP20200434T1 (hr) Stabilne vodene formulacije adalimumaba
JP2011088913A5 (https=)
HRP20241144T1 (hr) Stabilne formulacije lipida i lipozoma
BR112014011162A2 (pt) derivados purínicos para o tratamento de infecções virais
PH12013502549B1 (en) Fused benzoxazepinones as ion channel modulators
HRP20171175T1 (hr) Novi triciklički spojevi
JP2012092110A5 (https=)
HRP20220455T1 (hr) Modificirane aminokiseline koje sadrže azid grupu
PH12014502778A1 (en) Antibody formulation
HRP20180425T1 (hr) Čvrste kompozicije koje sadrže agonist glp-1 i sol n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline
GEP20156263B (en) Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for production and usage thereof
UA109421C2 (uk) Фармацевтична композиція, яка містить ліганди сигма-рецептора
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
EA201590161A1 (ru) Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона
MX391077B (es) Composiciones de fenfluramina y métodos de preparación de las mismas.
CA2920410C (en) Thienopiperidine derivative and use thereof
HRP20200332T1 (hr) Modifikator eksenatida i njegova primjena
BR112013004455A2 (pt) composições para fornecimento gástrico de agentes ativos
JP2013543872A5 (https=)
WO2015038689A3 (en) Cationic antiseptic compositions
JP2015519398A5 (https=)
EA201270653A1 (ru) Антагонист dpи его применение